Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC)-Reference-Cited by-同舟云学术

Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC)

Published:2015-07-06 Issue:3 Volume:3 Page:519-543
ISSN:2076-393X
Container-title:Vaccines
language:en
Short-container-title:Vaccines

Author:

Overholser Jay,Ambegaokar Kristen,Eze Siobhan,Sanabria-Figueroa Eduardo,Nahta Rita,Bekaii-Saab Tanios,Kaumaya Pravin

Funder

NIH

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Link

http://www.mdpi.com/2076-393X/3/3/519/pdf

Reference86 articles.

1. Global Cancer Statistics, 2002

2. The Strategy for Esophageal Cancer Control in High-risk Areas of China

3. Inhibition of Oesophageal Squamous Cell Carcinoma Progression by in vivo Targeting of Hyaluronan Synthesis

4. Adenocarcinoma of the esophagus: Risk factors and prevention;Heath;Oncology (Williston Park),2000

5. The Relation of Gastroesophageal Reflux Disease and Its Treatment to Adenocarcinomas of the Esophagus and Gastric Cardia

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Multifunctional Nanovaccines for Potent Personalized Immunotherapy of Acute Myeloid Leukemia;Advanced Materials;2024-08-22

2. Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification;Biomedicine & Pharmacotherapy;2024-05

3. The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines;Journal of Peptide Science;2024-04-03

4. Recent advances in targeted strategies for triple-negative breast cancer;Journal of Hematology & Oncology;2023-08-28

5. Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency;Frontiers in Oncology;2022-09-27